Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents
- 18 February 1978
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 6 (1) , 7-9
- https://doi.org/10.1016/0090-8258(78)90002-1
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- Evaluation of VP-16 and the Combination of Adriamycin and Vincristine in Advanced Breast CancerOncology, 1976